Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Antibodies and Antibody Drug Conjugates

Antibodies and Antibody Drug Conjugates

Date: Thursday, 29 September 2016 - Friday, 30 September 2016
Location: Bengaluru

Keynote Speakers

Andrew  Polson

Andrew Polson
Principal Scientist, Genentech

Rakesh  Kumar

Rakesh Kumar
Distinguished Professor and National Chair in Cancer Research, Rajiv Gandhi Centre for Biotechnology

Monideepa Roy

Monideepa Roy
Director- Research & Development, Invictus Oncology Pvt Ltd

V Nagaraja

V Nagaraja
President, JNCASR

Rathnam Chaguturu

Rathnam Chaguturu
CEO, Innovation Czar-iDDPartners


SELECTBIO brings to you its 2nd International conference on ADC Development & Manufacture "Antibodies and Antibody Drug Conjugates" on September 29-30 2016 in Le Méridien Bangalore Hotel in Bengaluru, India.

An innovative therapeutic application which combines the distinctive properties of monoclonal antibodies (mAbs) with the potent cytotoxic effect of small drug molecules is Antibody-drug conjugates or ADCs. This conference will be covering different aspects of ADC development and manufacture, right from the introduction to regulatory thereby ensuring comprehensive understanding of the subject. In addition this event will provide an excellent platform for knowledge sharing, collaborative research and networking with the scientists in the field of Antibody Engineering, Antibody drug conjugates, biopharmaceuticals and Cancer research.

This event is co-located with our 4th International Conference Drug Discovery India 2016. Running alongside the conferences will be an exhibition covering the latest advancements in the instrumentation for antibody and cell technologies related research and development. 

Agenda Topics

  • ADC Development - Issues and Challenges
  • Antibody Development & Engineering
  • Bioanalytical Strategies for ADCs
  • Novel Conjugation Technologies, Payload & Linkers
  • Strategies for Development of Specific and Targeted ADCs

Sponsorship and Exhibition Opportunities

Maninderjit Singh, Exhibition Manager

Confirmed Speakers to date

Pazhanimuthu Annamalai , Managing Director, AURA Biotechnologies Private Limited
Sanjay Bajaj, Managing Director, Select Biosciences India Pvt Ltd
Sanjeev Gupta, General Manager -Advanced Biotech Lab, Ipca Laboratories Ltd.
Mythili Kameswaran, Scientific Officer "G", Bhabha Atomic Research Centre
Lavleen Kumar Gupta, Director, IgY Immunologix India Pvt Ltd
T Mahesh, Research Scholar, JSS College of Pharmacy
Arumugam Muruganandam, Mananging Director & Chief Scientific Officer, Affigenix Biosolutions Pvt Ltd
Sanjay Nilapwar, Scientist (Development- ADC), MedImmune
Priyaranjan Pattanaik, Associate Research Director, Syngene International Ltd
Rajgopal Rudrarapu, Research Associate, Aurobindo Pharma

Invited Speakers

Jens Lohrmann, Senior Global Program Manager- Translational Clinical Oncology, Novartis Institutes for BioMedical Research

Corporate Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery WoMetaTagsrld U-Networks

Add to Calendar ▼2016-09-29 00:00:002016-09-30 00:00:00Europe/LondonAntibodies and Antibody Drug ConjugatesAntibodies and Antibody Drug Conjugates in